24
WOCN® Society’s 49 th Annual Conference May 19 – 23, 2017 Abstract Submission Process

Abstract Submission Instructions 2017

Embed Size (px)

Citation preview

Page 1: Abstract Submission Instructions 2017

WOCN® Society’s 49th Annual ConferenceMay 19 – 23, 2017

Abstract Submission Process

Page 2: Abstract Submission Instructions 2017

Why do I have to view this?

• We are pleased to offer Continuing Education credit for poster sessions and must be compliant with regulatory criteria in our abstract and poster process.

• The information contained in this tutorial, when applied correctly to the abstract, will increase the chances that the abstract is accepted.

• Not following the rules and information makes your abstract subject to automatic rejection, which is very avoidable!

Page 3: Abstract Submission Instructions 2017

Author Information

• ALL authors’ names must be “declared” or listed at the time of submission.• Once the abstract is submitted, no other author names can be added.• Only appropriate VALID and CURRENT credentials for each author should be

usedEXAMPLE:

T. Weedledee BSN, RN, WOCN INCORRECTT. Weedledee BSN, RN, CWOCN CORRECT!!

Page 4: Abstract Submission Instructions 2017

Author Information: Conflict of Interest

• Every named author must complete the required conflict of interest (COI) form.• In order for the abstract to be considered ready for review, each author

must have their COI submitted by the abstract submission deadline, 11:00 AM EST/8:00 AM PST, WEDNESDAY, NOVEMBER 2, 2016.• It is the PRIMARY author’s responsibility to inform the other authors of the

requirement to complete the COI. Ultimately the primary author is responsible to make sure the other authors complete the COI document.

Page 5: Abstract Submission Instructions 2017

Author Information: VERY IMPORTANT

All contributing authors should be listed now. There will NOT be any opportunity to add authors later….

THIS IS THE ONLY OPPORTUNITY

Page 6: Abstract Submission Instructions 2017

How do we decide to award CE for the posters?

• All accepted abstract submissions will be reviewed by the designated Nurse Planner.

• The relevant relationships (that create conflicts of interest) disclosed by authors and contributors is how we decide to award CE.

• A poster is not eligible for CE if there is a relevant relationship between the authors/content and any commercial/industry company.

Page 7: Abstract Submission Instructions 2017

CNE Content Integrity• The Wound, Ostomy and Continence Nurses Society is accredited as a provider

of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.• As such, we must ensure that the content of any activity accredited for

continuing nursing education (CNE) adheres to the criteria, standards and policies dictated by the ANCC (and affiliated accrediting entities). • To do so, we must receive information from you to help us determine if you have

a conflict of interest. • This is outlined by the ANCC in their Content Integrity Standards.

Page 8: Abstract Submission Instructions 2017

Definitions• The American Nurses Credentialing Center (ANCC) defines an organization as

having a commercial interest (“Commercial Interest Organization”)* if it: • Produces, markets, sells or distributes health care goods or services consumed by or used on patients; • Is owned or operated, in whole or in part, by an organization that produces, markets, sells or distributes

health care goods or services consumed by or used on patients; or • Advocates for use of the products or services of commercial interest organizations. • (*Reference: Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial

Support, August 2007 (www.accme.org) - ANCC’s definition is intended to ensure compliance with Food and Drug Administration Guidance on Industry-Supported Scientific and Educational Activities and consistency with the ACCME definition)

• Relevant relationships, as defined by ANCC, are relationships with a commercial interest if the products or services of the commercial interest are related to the content of the educational activity.

Page 9: Abstract Submission Instructions 2017

Who must disclose?• All persons in a position to control or exert influence over the content of a

CNE activity MUST disclose to WOCN all relevant relationships with a commercial interest (as defined on the prior page)• The ANCC considers relationships of a spouse, partner or close family

member to be those of the person disclosing. • Any person who does not disclose will be excused from participation in the

CNE portion of the activity.

Page 10: Abstract Submission Instructions 2017

What information must be disclosed?

• Relationships with any commercial interest of the individual’s spouse/partner may be relevant relationships and must be reported, evaluated, and resolved.

• Evidence of a relevant relationship with a commercial interest may include but is not limited to receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (stock and stock options, excluding diversified mutual funds), grants, contracts, or other financial benefit directly or indirectly from the commercial interest.

• Financial benefits may be associated with employment, management positions, independent contractor relationships, other contractual relationships, consulting, speaking, teaching, membership on an advisory committee or review panel, board membership, and other activities from which remuneration is received or expected from the commercial interest.

• If the research or costs of producing the content to be used in this activity were funded in part or whole by a commercial interest; this includes in-kind donations, travel expenses, production of posters, handouts, etc.

Page 11: Abstract Submission Instructions 2017

What does WOCN do with the information?

• Information disclosed to WOCN is reviewed to determine if a conflict of interest exists. • The WOCN Lead Nurse Planner (LNP) will work with the discloser to resolve the

conflict, this includes but is not limited to;• limiting the participation of the individual, • peer review of content, • excusing the individual, • not awarding contact hours for the portion of the activity, and;• as otherwise warranted by the WOCN LNP.

• The information is also used to disclose to the audience.

Page 12: Abstract Submission Instructions 2017

Further Protecting Against Bias

• Generic Names• Use of GENERIC name of products is allowed in the body of the abstract and in the poster/oral

presentations. If mentioned in titles, the GENERIC names of products are to be used. • Brand names and company names may be identified only once in an acknowledgement section. • Presentations that constitute promotion and advertising, including pervasive or inappropriate use of

logos will not be accepted. • No company product information may be displayed or disseminated in conjunction with the oral or

poster presentation. • If the cost of a presentation has been underwritten to any extent, a disclosure stating the support and

identifying the source will be required at the time of the abstract submission and will be required with the oral or poster presentation (e.g., "The support of [Corporation or Institution] for this project is gratefully acknowledged.").

• Statements should not be viewed as or considered representative of any formal stance or position taken on any subject, issue, or product by the WOCN® Society.

Page 13: Abstract Submission Instructions 2017

Further Protecting Against Bias

• Company Logos, Slogans or Tag Lines• The logos, slogans or tag lines (or for that matter any marketing or advertising content) of a commercial

interest are not to be used in presentations. • Further, WOCN strongly advises against the use of any company logos, tag lines or slogans in the content

of a presentation, regardless of the company’s status as a commercial interest. • While the policies are intended to protect against undue influence by commercial interests, WOCN also

recognizes that other organizations, not meeting the definition of commercial support may stand to benefit financially by the promotion of their company or products/services and this may create a bias for the planners or faculty who have a relationship with the company.

• The test for this is to ask yourself if the audience members are customer targets of the entity whose logo or materials are to be presented. • If the answer is yes, then WOCN recommends against use. Please consider this in the development

and presentation of your abstract.

Page 14: Abstract Submission Instructions 2017

Copyrights/Patents & Attribution

• Please provide appropriate symbols and references and secure all permissions if dealing with copyrighted material and/or patents. • This is solely the author(s) responsibility to secure these permissions. • The WOCN® Society has no responsibility whatsoever in securing these

permissions.• Please give credit to all references used in the development of the

abstract/poster. Oversight of reference may result in abstract/poster rejection.

Page 15: Abstract Submission Instructions 2017

General Information• Reminder that abstracts should reflect COMPLETED work, not anticipated

work. Incomplete results would be cause for the abstract to be rejected. All work should be completed prior to abstract submission.• The Case Study category requires at least 3 cases, but could include more.

It would be considered RARE, to submit a one case scenario unless it is especially unique, which would be to say that the condition is so very rare, or the solution so groundbreaking that it has not been discussed before, for example.

Page 16: Abstract Submission Instructions 2017

General Information• Facility/Company/Personal Names do not belong in the abstract, and

would be justification for rejection of the abstract.• No Protected Health Information (PHI) is to appear in the slidesSuggestions for Agency:“Small rural hospital in the Midwest”“Level I trauma center in the Northeast USA”“Academic hospital located in the Southwestern United States”

Page 17: Abstract Submission Instructions 2017

General Information

• Use appropriate terms—standardization is best• “WOC nurse” instead of “the CWOCN” or “the WOCN”• WOCN® Society—reflects our legal name

Page 18: Abstract Submission Instructions 2017

General Information• Product information should be discussed in generic terms

Examples:Moldable ostomy barrier

Silver impregnated foam dressingMulti-layer compression system

Low Frequency UltrasoundNegative Pressure Wound Therapy

Medications: “Ibuprofen” (appropriate) vs “Advil”• In the “Acknowledgement” Section of your poster, you may clarify these generics, but

this section does not appear in the Abstract Submission Process.

Page 19: Abstract Submission Instructions 2017

General Information• Before submitting the abstract, ask someone to independently review it for

grammar, spelling, and clarity of communication of the information.• Be concise—the abstract is an eagle’s eye overview of the work. But it is

the commercial to make the reader understand what is included and what the topic is about as well.• Do NOT wait until the last minute….anything could happen….

Computer crashes, bad weather, illness, and LIFE…..begin early!!

Page 20: Abstract Submission Instructions 2017

General Information• If you are submitting an abstract, anticipate that it will be accepted, and

make arrangements for conference registration early—• The primary author will be expected to register for the conference upon

notification of acceptance of the abstract. There is generally only 30 days after notification to register, so be prepared to do so!! • Registration means that the conference fee is paid, and this serves as a

means to confirm your attendance to present your poster!

Page 21: Abstract Submission Instructions 2017

General Information• Posters will be displayed throughout the conference, and the CE poster

session will be held on Monday of the conference.• Primary authors are expected to be present at their poster during the CE

poster session.• If you are a first time abstract presenter, please indicate that when asked.• If your abstract focuses on prevention, please indicate that when asked.• Please note that only research category abstracts will be considered for

oral presentation at the conference. However, even if the information is presented orally, a poster may still be displayed.

Page 22: Abstract Submission Instructions 2017

General Information• Specific instructions on posters, including how to cite references, how to

acknowledge your agency, how to acknowledge vendor support, how to use logos and so on, will be sent to you if your abstract is accepted for poster presentation.• Oral presentations will be reviewed by the Abstract Chair or designee, or

the Education Committee/Consultant, and other instructions regarding that process will follow should podium presentation invitation be given.

Page 23: Abstract Submission Instructions 2017

Good luck with the submission process!!

If you have any questions, please reach out!

Jody Scardillo, DNP, RN, ANP-BC, CWOCNAbstract Chair

National Conference Planning Committee [email protected]

Email Subject: Abstract Question

National Office Contact:Brooke Passy, [email protected]

Page 24: Abstract Submission Instructions 2017

References1. American Nursing Credentialing Center’s Content Integrity

Standards (2014). Retrieved from: http://www.nursecredentialing.org/Accreditation/ResourcesServices/Accreditation-CEContentIntegrity